Cognyxx Pharmaceuticals
Treatment for Cardiovascular and Neurodegenerative Disorders
Startup Pre-Funding Health Tech & Life Sciences Est. 2018
🌐 Website
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
3
1-10 employees
Confidence
78/100
About
Cognyxx Pharmaceuticals is developing a solution to empower the immune system in treatments for cardiovascular and neurodegenerative disorders.
Classification
Sector
Health Tech & Life SciencesPharma & Medical Biotechnology
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
degenerative-diseasesneurosciencecardiology
Details
Product Stage
R&D
Employees
1-10
Exact Count
6
Founded
2018
Registrar
515863181
Locations
Derech Menachem Begin 132, Tel Aviv-Yafo, Israel
Links
Website
www.cognyxx.com
Admin
Last Update
Sep 4, 2025
Verified by
Yanina Wainscheinker
Missing
description, video or image, funding rounds, news, markets, external profiles, not claimed
Team (3)
Jacob George
Co-founder
Founder
Mike Fassler
Co-founder & CSO
Founder
Clara Benaim
Head of R&D
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2018-07-10T00:00:00.000Z
Last editor
Yotam Maman (yotamm1988@gmail.com)
Finder · Cognyxx Pharmaceuticals · 2026